Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2022: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Mannatech, Incorporated✕ MTEX · #25,531 in the world | PURE Bioscience, Inc.✕ PURE |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | FMCG | FMCG |
| Founded | 1994 | — |
| Size | ||
| Market cap | ||
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Mannatech, Incorporated | PURE Bioscience, Inc. |
|---|---|---|
| 2026 | — | $2 MSEC |
| 2025 | $108 MSEC | $2 MSEC |
| 2024 | $118 MSEC | $2 MSEC |
| 2023 | $132 MSEC | $2 MSEC |
| 2022 | $137 MSEC | $2 MSEC |
| 2021 | $160 MSEC | $4 MSEC |
| 2020 | $151 MSEC | $7 MSEC |
| 2019 | $158 MSEC | $2 MSEC |
| 2018 | $174 MSEC | $2 MSEC |
| 2017 | $177 MSEC | $2 MSEC |
| 2016 | $180 MSEC | $1 MSEC |
| 2015 | $180 MSEC | $1 MSEC |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $12 M |
| $9 M* |
| Revenue | $108 M | $2 M |
|---|
| Net income | $-15 M | $-2 M▲ best |
|---|
| Employees | — | 10 |
|---|
| Valuation | ||
|---|---|---|
| Price to sales | 0.1× | — |
| Free cash flow yield | -35.9% | — |
| Profitability | ||
|---|---|---|
| Gross margin | 74.9%▲ best | 57.3% |
| Operating margin | -0.4%▲ best | -89.7% |
| Net margin | -14.1%▲ best | -106.9% |
| Growth | ||
|---|---|---|
| Revenue growth | -8.3% | 5.5%▲ best |
| Revenue growth, 3 years a year | -7.7% | 7.5%▲ best |
| Financial strength | ||
|---|---|---|
| Net debt to EBITDA | -5.2× | — |
| Interest cover | -1.1×▲ best | -5.1× |
| Cash | ||
|---|---|---|
| Free cash flow margin | -4.0% | — |
| Altman Z-score zone | safe | — |
|---|
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Jul 2023; ratios FY2026 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.